
PolyCore Therapeutics Secures Seed Financing to Address Motor Symptoms and Dyskinesia Associated with Parkinson’s Disease
– Collaboration with Xontogeny provides funding and key advisory support for early development – PHILADELPHIA, Pa, April 11, 2022 – PolyCore Therapeutics, Inc., a biopharmaceutical… Read More